nach oben

coloproctology

Erschienen in:

27.10.2017 | Rektumkarzinom | CME

Chirurgische Therapie des Karzinoms des unteren Rektumdrittels

verfasst von: PD Dr. A. D. Rink

Erschienen in: coloproctology | Ausgabe 6/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Therapie des Karzinoms des unteren Rektumdrittels steht im Spannungsfeld zwischen der notwendigen onkologischen Radikalität und dem Erhalt der Kontinenz. Voraussetzung für eine optimale Therapie ist eine subtile präoperative Diagnostik, in dessen Mittelpunkt die proktologische Untersuchung durch den erfahrenen Chirurgen und die Magnetresonanztomographie stehen. Neben der tiefen anterioren Resektion mit koloanaler Rekonstruktion kommen die partielle oder die komplette intersphinktäre Resektion als kontinenzerhaltende Verfahren zum Einsatz. Für die abdominoperineale Exstirpation (APE) stehen die intersphinktäre, die Standard- und die extralevatorische APE zur Verfügung. Neue Operationsverfahren wie die transanale totale mesorektale Exzision (TaTME) und die roboterassistierte TME könnten zu einer Verbesserung der funktionellen und onkologischen Ergebnisse gerade bei Karzinomen des unteren Rektumdrittels beitragen, sind zurzeit aber noch in Erprobung.

Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, de Lange-de Klerk ES et al (2015) A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 372(14):1324–1332CrossRefPubMed

Stelzner F, Biersack HJ, von Mallek D (2006) Imaging, anatomic, and surgical considerations for rectal organs and function following radical resection of a rectal carcinoma. Chirurg 77(3):273–280CrossRefPubMed

Rullier E, Denost Q, Vendrely V, Rullier A, Laurent C (2013) Low rectal cancer: classification and standardization of surgery. Dis Colon Rectum 56(5):560–567CrossRefPubMed

Orkin BA, Sinykin SB, Lloyd PC (2010) The digital rectal examination scoring system (DRESS). Dis Colon Rectum 53(12):1656–1660CrossRefPubMed

Knol JJ, D’Hondt M, Souverijns G, Heald B, Vangertruyden G (2015) Transanal endoscopic total mesorectal excision: technical aspects of approaching the mesorectal plane from below–a preliminary report. Tech Coloproctol 19(4):221–229CrossRefPubMed

Nougaret S, Reinhold C, Mikhael HW, Rouanet P, Bibeau F, Brown G (2013) The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? Radiology 268(2):330–344CrossRefPubMed

Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G et al (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: the MERCURY II study. Ann Surg 263(4):751–760CrossRefPubMed

Heald RJ, Husband EM, Ryall RD (1982) The mesorectum in rectal cancer surgery–the clue to pelvic recurrence? Br J Surg 69(10):613–616CrossRefPubMed

Scott N, Jackson P, al-Jaberi T, Dixon MF, Quirke P, Finan PJ (1995) Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg 82(8):1031–1033CrossRefPubMed

10.

Guillem JG, Chessin DB, Shia J, Suriawinata A, Riedel E, Moore HG et al (2007) A prospective pathologic analysis using whole-mount sections of rectal cancer following preoperative combined modality therapy – implications for sphincter preservation. Ann Surg 245(1):88–93CrossRefPubMedPubMedCentral

11.

Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following ‘curative’ surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg 71(1):17–20CrossRefPubMed

12.

Pahlman L, Bujko K, Rutkowski A, Michalski W (2013) Altering the therapeutic paradigm towards a distal bowel margin of 〈 1 cm in patients with low-lying rectal cancer: a systematic review and commentary. Colorectal Dis 15(4):E166–E74CrossRefPubMed

13.

Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer R (2012) What is a safe distal resection margin in rectal cancer patients treated by low anterior resection without preoperative radiotherapy? Colorectal Dis 14(2):e48–e55CrossRefPubMed

14.

Pox C, Aretz S, Bischoff SC, Graeven U, Hass M, Heussner P et al (2013) S3-guideline colorectal cancer version 1.0. Z Gastroenterol 51(8):753–854CrossRefPubMed

15.

Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303–312CrossRefPubMed

16.

Park JS, Huh JW, Park YA, Cho YB, Yun SH, Kim HC et al (2014) A circumferential resection margin of 1 mm is a negative prognostic factor in rectal cancer patients with and without neoadjuvant chemoradiotherapy. Dis Colon Rectum 57(8):933–940CrossRefPubMed

17.

Hwang MR, Park JW, Park S, Yoon H, Kim DY, Chang HJ et al (2014) Prognostic impact of circumferential resection margin in rectal cancer treated with preoperative chemoradiotherapy. Ann Surg Oncol 21(4):1345–1351CrossRefPubMed

18.

Emmertsen KJ, Laurberg S, Rectal Cancer Function Study Group (2013) Impact of bowel dysfunction on quality of life after sphincter-preserving resection for rectal cancer. Br J Surg 100(10):1377–1387CrossRefPubMed

19.

Juul T, Ahlberg M, Biondo S, Emmertsen KJ, Espin E, Jimenez LM et al (2014) International validation of the low anterior resection syndrome score. Ann Surg 259(4):728–734CrossRefPubMed

20.

Emmertsen KJ, Laurberg S (2012) Low anterior resection syndrome score: development and validation of a symptom-based scoring system for bowel dysfunction after low anterior resection for rectal cancer. Ann Surg 255(5):922–928CrossRefPubMed

21.

Rink AD, Sgourakis G, Sotiropoulos GC, Lang H, Vestweber KH (2009) The colon J‑pouch as a cause of evacuation disorders after rectal resection: myth or fact? Langenbecks Arch Surg 394(1):79–91CrossRefPubMed

22.

Pachler J, Wille-Jorgensen P (2012) Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004323.pub4 PubMed

23.

Grumann MM, Noack EM, Hoffmann IA, Schlag PM (2001) Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg 233(2):149–156CrossRefPubMedPubMedCentral

24.

Kornmann VN, Walma MS, de Roos MA, Boerma D, van Westreenen HL (2016) Quality of life after a low anterior resection for rectal cancer in elderly patients. Ann Coloproctol 32(1):27–32CrossRefPubMedPubMedCentral

25.

Bregendahl S, Emmertsen KJ, Lous J, Laurberg S (2013) Bowel dysfunction after low anterior resection with and without neoadjuvant therapy for rectal cancer: a population-based cross-sectional study. Colorectal Dis 15(9):1130–1139PubMed

26.

Denost Q, Laurent C, Capdepont M, Zerbib F, Rullier E (2011) Risk factors for fecal incontinence after intersphincteric resection for rectal cancer. Dis Colon Rectum 54(8):963–968CrossRefPubMed

27.

Lee TG, Kang SB, Heo SC, Jeong SY, Park KJ (2011) Risk factors for persistent anal incontinence after restorative proctectomy in rectal cancer patients with anal incontinence: prospective cohort study. World J Surg 35(8):1918–1924CrossRefPubMed

28.

Contin P, Kulu Y, Bruckner T, Sturm M, Welsch T, Muller-Stich BP et al (2014) Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis 29(2):165–175CrossRefPubMed

29.

Runkel N, Reiser H (2013) Nerve-oriented mesorectal excision (NOME): autonomic nerves as landmarks for laparoscopic rectal resection. Int J Colorectal Dis 28(10):1367–1375CrossRefPubMed

30.

Reißfelder C, Kirchberg J, Weitz J (2014) Nervenschonende offene tiefe anteriore Rektumresektion beim Rektumkarzinom. Zentralbl Chir 139(04):381–383CrossRefPubMed

31.

Heriot AG, Tekkis PP, Constantinides V, Paraskevas P, Nicholls RJ, Darzi A et al (2006) Meta-analysis of colonic reservoirs versus straight coloanal anastomosis after anterior resection. Br J Surg 93(1):19–32CrossRefPubMed

32.

Fazio VW, Zutshi M, Remzi FH, Parc Y, Ruppert R, Furst A et al (2007) A randomized multicenter trial to compare long-term functional outcome, quality of life, and complications of surgical procedures for low rectal cancers. Ann Surg 246(3):481–488 (discussion 8–90)CrossRefPubMedPubMedCentral

33.

Hida J, Yasutomi M, Fujimoto K, Okuno K, Ieda S, Machidera N et al (1996) Functional outcome after low anterior resection with low anastomosis for rectal cancer using the colonic J‑pouch. Prospective randomized study for determination of optimum pouch size. Dis Colon Rectum 39(9):986–991CrossRefPubMed

34.

Lazorthes F, Gamagami R, Chiotasso P, Istvan G, Muhammad S (1997) Prospective, randomized study comparing clinical results between small and large colonic J‑pouch following coloanal anastomosis. Dis Colon Rectum 40(12):1409–1413CrossRefPubMed

35.

Huttner FJ, Tenckhoff S, Jensen K, Uhlmann L, Kulu Y, Buchler MW et al (2015) Meta-analysis of reconstruction techniques after low anterior resection for rectal cancer. Br J Surg 102(7):735–745CrossRefPubMed

36.

Denost Q, Adam JP, Rullier A, Buscail E, Laurent C, Rullier E (2014) Perineal transanal approach: a new standard for laparoscopic sphincter-saving resection in low rectal cancer, a randomized trial. Ann Surg 260(6):993–999CrossRefPubMed

37.

den Dulk M, Putter H, Collette L, Marijnen CA, Folkesson J, Bosset JF et al (2009) The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 45(7):1175–1183CrossRef

38.

Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK (1998) Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg 133(8):894–899CrossRefPubMed

39.

Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J (2007) Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94(2):232–238CrossRefPubMed

40.

Stelzner S, Hellmich G, Sims A, Kittner T, Puffer E, Zimmer J et al (2016) Long-term outcome of extralevator abdominoperineal excision (ELAPE) for low rectal cancer. Int J Colorectal Dis 31(10):1729–1737CrossRefPubMed

41.

Stelzner S, Holm T, Moran BJ, Heald RJ, Witzigmann H, Zorenkov D et al (2011) Deep pelvic anatomy revisited for a description of crucial steps in extralevator abdominoperineal excision for rectal cancer. Dis Colon Rectum 54(8):947–957CrossRefPubMed

42.

West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P (2008) Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26(21):3517–3522CrossRefPubMed

43.

Han JG, Wang ZJ, Wei GH, Gao ZG, Yang Y, Zhao BC (2012) Randomized clinical trial of conventional versus cylindrical abdominoperineal resection for locally advanced lower rectal cancer. Am J Surg 204(3):274–282CrossRefPubMed

44.

Martijnse IS, Dudink RL, West NP, Wasowicz D, Nieuwenhuijzen GA, van Lijnschoten I et al (2012) Focus on extralevator perineal dissection in supine position for low rectal cancer has led to better quality of surgery and oncologic outcome. Ann Surg Oncol 19(3):786–793CrossRefPubMed

45.

Huang A, Zhao H, Ling T, Quan Y, Zheng M, Feng B (2014) Oncological superiority of extralevator abdominoperineal resection over conventional abdominoperineal resection: a meta-analysis. Int J Colorectal Dis 29(3):321–327CrossRefPubMed

46.

Klein M, Fischer A, Rosenberg J, Gogenur I, Danish Colorectal Cancer G (2015) Extralevatory abdominoperineal excision (ELAPE) does not result in reduced rate of tumor perforation or rate of positive circumferential resection margin: a nationwide database study. Ann Surg 261(5):933–938CrossRefPubMed

47.

Prytz M, Angenete E, Ekelund J, Haglind E (2014) Extralevator abdominoperineal excision (ELAPE) for rectal cancer–short-term results from the Swedish Colorectal Cancer Registry. Selective use of ELAPE warranted. Int J Colorectal Dis 29(8):981–987CrossRefPubMedPubMedCentral

48.

Smedh K, Sverrisson I, Chabok A, Nikberg M, Group HACS (2016) Hartmann’s procedure vs abdominoperineal resection with intersphincteric dissection in patients with rectal cancer: a randomized multicentre trial (HAPIrect). BMC Surg 16(1):43CrossRefPubMedPubMedCentral

49.

Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ et al (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the AlacaRT randomized clinical trial. JAMA 314(13):1356–1363CrossRefPubMed

50.

Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M et al (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314(13):1346–1355CrossRefPubMedPubMedCentral

51.

van der Pas MH, Haglind E, Cuesta MA, Furst A, Lacy AM, Hop WC et al (2013) Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol 14(3):210–218CrossRefPubMed

52.

Rink AD, Kauff DW, Paschold M, Vestweber KH, Lang H, Kneist W (2015) Hybrid TAMIS total mesorectal excision : a new perspective in treatment of distal rectal cancer – technique and results. Chirurg 87(3):225–232. https://doi.org/10.1007/s00104-015-0043-7 CrossRef

53.

Lacy AM, Tasende MM, Delgado S, Fernandez-Hevia M, Jimenez M, De Lacy B et al (2015) Transanal total mesorectal excision for rectal cancer: outcomes after 140 patients. J Am Coll Surg 221(2):415–423CrossRefPubMed

54.

Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH et al (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20(7):1729–1734CrossRefPubMed

55.

Rink AD, Vestweber KH (2017) Die laparoskopisch-assistierte transanale TME (TaTME) – Technik und Erfahrungen. Chir Prax 82:1–18

56.

Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, Sietses C et al (2016) COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 30(8):3210–3215CrossRefPubMed

57.

Aigner F, Biebl M, Furst A, Jons T, Pratschke J, Kneist W (2017) Training course transanal total mesorectal excision (TaTME) : concept and establishment of a training course for safe application. Chirurg 88(2):147–154CrossRefPubMed

58.

Williams NS, Murphy J, Knowles CH (2008) Anterior Perineal PlanE for Ultra-low Anterior Resection of the Rectum (the APPEAR technique): a prospective clinical trial of a new procedure. Ann Surg 247(5):750–758CrossRefPubMed

59.

Grade M, Ridwelski K, Voigt I, Ghadimi BM, Mann B (2016) Robotic rectal cancer surgery. Zentralbl Chir 141(2):165–169CrossRefPubMed

60.

ROLARR-Studie L‑SM (2016) Roboter schneidet am Darm gut ab. Dtsch Arztebl 113(19):A944

61.

Bordeianou L, Maguire LH, Alavi K, Sudan R, Wise PE, Kaiser AM (2014) Sphincter-sparing surgery in patients with low-lying rectal cancer: techniques, oncologic outcomes, and functional results. J Gastrointest Surg 18(7):1358–1372CrossRefPubMedPubMedCentral

Titel: Chirurgische Therapie des Karzinoms des unteren Rektumdrittels
verfasst von: PD Dr. A. D. Rink
Publikationsdatum: 27.10.2017
Verlag: Springer Medizin
Schlagwörter: Rektumkarzinom
Rektumkarzinom
Erschienen in: coloproctology / Ausgabe 6/2017
Print ISSN: 0174-2442
Elektronische ISSN: 1615-6730
DOI: https://doi.org/10.1007/s00053-017-0199-3

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2017

Mitteilungen der SAKP

Onkologische Ergebnisse nach robotischer tiefer anteriorer Rektumresektion

Laparoskopisches Management der Insuffizienz nach Rektumresektion

Langzeitergebnisse vorbestrahlter Rektumkarzinome ypT0

Mitteilungen des BCD und der DGK

Transanale totale mesorektale Exzision (TaTME) bei primärem Rektumkarzinom